Else Nutrition GH Ltd. – Trademark Portfolio
Entity Type: 16
Else Nutrition GH Ltd. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 29 (Meats & Processed Foods) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include ELSE and ELSE NUTRITION. The owner is based in Tel Aviv-Yafo.
4 Raul Walenberg Street
Tel Aviv-Yafo , IL
Showing of trademarks Trademarks
Trademark Classifications
Else Nutrition GH Ltd.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does Else Nutrition GH Ltd. have?
Else Nutrition GH Ltd. has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 abandoned.
What trademark classes does Else Nutrition GH Ltd. file in?
Else Nutrition GH Ltd. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Else Nutrition GH Ltd.'s most well-known trademarks?
Else Nutrition GH Ltd.'s registered trademark portfolio includes well-known marks such as ELSE and ELSE NUTRITION. These are among 3 currently registered trademarks in the portfolio.
What is Else Nutrition GH Ltd.'s trademark registration success rate?
Else Nutrition GH Ltd. has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.